journal article·2022-06Open access

Truncated vascular endothelial cadherin enhances rapid endothelialization of small diameter synthetic vascular grafts

Bob S.L. Lee, Nianji. Yang, Miguel. Santos, Matthew J. Moore, Angus J. Grant, Jun-Hyeog Jang, Behnam Akhavan, Marcela M. Bilek, Richard P. Tan, Steven G. Wise

Abstract

Complete and rapid endothelialization is critical to the long-term performance of synthetic vascular grafts. A fully formed endothelium is resistant to thrombosis and mitigates the development of neointimal hyperplasia, the dominant modes of acute and chronic graft failure, respectively. Significant research efforts aim to develop strategies which enhance graft endothelialization through the incorporation of surface ligands that promote the attachment and growth of endothelial cells. In native vessels these functions are regulated by the adhesion molecule vascular endothelial cadherin (VE-Cad). VE-Cad is exclusive to endothelial cells and possesses high self-affinity, forming homodimers with VE-Cad on adjacent endothelial cells. Leveraging this targeted binding ability, we developed a graft functionalization approach using a recombinant truncated form of VE-Cad (VEtr). VEtr contains only the domains responsible for self-interaction, recognition and adhesion. Using the plasma functionalization technique, plasma immersion ion implantation (PIII) technique we immobilize VEtr onto the surface of electrospun polycaprolactone (PCL). VEtr scaffolds achieved a nearly 2-fold increase in attachment and spreading, and a 2.5-fold increase in proliferation of human coronary artery endothelial cells (HCAECs) compared with control scaffolds in vitro. Following 14-day implantation in a mouse carotid artery model, VEtr grafts showed ∼90% CD31-positive endothelial coverage. The benefits of this enhanced endothelialization included an ∼88% reduction in fibrin deposition (early thrombosis) as well as ∼63% reduction in macrophage recruitment (early neointimal hyperplasia). These findings highlight VEtr functionalization as a promising approach for rapid graft endothelialization which may potentially improve the long-term performance of synthetic vascular grafts.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Polymer Surface Interaction Studies · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (52)

Show source-provided references
1. Adhesion of endothelial cells and adsorption of serum proteins on gas plasma-treated polytetrafluoroethylene10.1016/0142-9612(91)90191-C ↗
2. Physicochemical properties and in vitro biocompatibility of three bacterial nanocellulose conduits for blood vessel applications, Carbohydr
3. Rapid endothelialization of off-the-shelf small diameter silk vascular grafts10.1016/j.jacbts.2017.12.003 ↗
4. Vascular prostheses for aortocoronary bypass grafting: a review10.1111/j.1525-1594.1995.tb02242.x ↗
5. Six years of clinical follow-up with endothelial cell-seeded small-diameter vascular grafts during coronary bypass surgery
6. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature10.1016/j.ejvs.2003.12.027 ↗
7. A contemporary meta-analysis of Dacron versus polytetrafluoroethylene grafts for femoropopliteal bypass grafting10.1016/j.jvs.2010.02.010 ↗
8. Improved endothelialization and reduced thrombosis by coating a synthetic vascular graft with fibronectin and stem cell homing factor SDF-1α10.1016/j.actbio.2011.09.016 ↗
9. Endothelialization and patency of RGD-functionalized vascular grafts in a rabbit carotid artery model10.1016/j.biomaterials.2011.12.047 ↗
10. The selective modulation of endothelial cell mobility on RGD peptide containing surfaces by YIGSR peptides10.1016/j.biomaterials.2004.02.012 ↗
11. New trends in the development of multifunctional peptides to functionalize biomaterials10.1002/psc.3335 ↗
12. Small-diameter synthetic vascular graft immobilized with the REDV peptide reduces early-stage fibrin clot deposition and results in graft patency in rats10.1021/acs.biomac.0c00457 ↗
13. Vascular transplantation with dual-biofunctional ePTFE vascular grafts in a porcine model10.1039/D1TB01398J ↗
14. Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation10.1161/ATVBAHA.111.226134 ↗
15. Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability10.1182/blood.V97.6.1679 ↗
16. Human VE-cadherin fusion protein as an artificial extracellular matrix enhancing the proliferation and differentiation functions of endothelial cell10.1021/acs.biomac.5b01467 ↗
17. VE-cadherin at a glance10.1007/s00441-014-1843-7 ↗
18. Evaluation of synthetic vascular grafts in a mouse carotid grafting model10.1371/journal.pone.0174773 ↗
19. Bioactive materials facilitating targeted local modulation of inflammation10.1016/j.jacbts.2018.10.004 ↗
20. Plasma-treated polyethylene surfaces for improved binding of active protein10.1002/ppap.200600182 ↗
21. Immobilized macrophage colony-stimulating factor (M-CSF) regulates the foreign body response to implanted materials10.1021/acsbiomaterials.9b01887 ↗
22. Mussel adhesive protein fused with VE-cadherin domain specifically triggers endothelial cell adhesion10.1039/C8TB00526E ↗
23. Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state10.1074/jbc.M505568200 ↗
24. Endothelial cell adhesion to the fibronectin CS5 domain in artificial extracellular matrix proteins10.1016/S0142-9612(03)00294-1 ↗
25. Effect of hypoxia on integrin-mediated adhesion of endothelial progenitor cells10.1111/j.1582-4934.2012.01553.x ↗
26. Effect of plasma ion immersion implantation on physiochemical and biological properties of silk towards creating a versatile biomaterial platform10.1016/j.mtadv.2022.100212 ↗
27. Plasma ion implantation of silk biomaterials enabling direct covalent immobilization of bioactive agents for enhanced cellular responses10.1021/acsami.8b03182 ↗
28. Immobilisation of a fibrillin-1 fragment enhances the biocompatibility of PTFE10.1016/j.colsurfb.2014.01.042 ↗
29. Surface plasma modification and tropoelastin coating of a polyurethane co-polymer for enhanced cell attachment and reduced thrombogenicity10.1016/j.biomaterials.2014.04.082 ↗
30. Prediction of protein orientation upon immobilization on biological and nonbiological surfaces10.1073/pnas.0605841103 ↗
31. Altered processing enhances the efficacy of small-diameter silk fibroin vascular grafts10.1038/s41598-019-53972-y ↗
32. VE-cadherin simultaneously stimulates and inhibits cell proliferation by altering cytoskeletal structure and tension10.1242/jcs.00680 ↗
33. Vascular endothelial-cadherin regulates cytoskeletal tension, cell spreading, and focal adhesions by stimulating RhoA10.1091/mbc.e03-10-0745 ↗
34. VE-cadherin: adhesion at arm's length10.1152/ajpcell.00522.2003 ↗
35. VE-cadherin, arterioscler10.1161/ATVBAHA.107.158014 ↗
36. Mussel adhesive protein fused with VE-cadherin extracellular domain promotes endothelial-cell tight junctions and in vivo endothelization recovery of vascular stent10.1002/jbm.b.34369 ↗
37. Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities10.1186/1755-8794-3-18 ↗
38. Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy10.1167/iovs.09-4951 ↗
39. Outgrowth endothelial cells: sources, characteristics and potential applications in tissue engineering and regenerative medicine
40. The NO cascade, eNOS location, and microvascular permeability10.1093/cvr/cvq139 ↗
41. Endothelial nitric oxide synthase10.1161/01.ATV.0000109171.50229.33 ↗
42. The clinical significance of endothelial dysfunction10.1097/01.hco.0000179821.11071.79 ↗
43. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model10.1016/j.jvs.2004.01.046 ↗
44. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model10.1016/j.jss.2003.12.026 ↗
45. Synthetic ePTFE grafts coated with an anti-CD133 antibody-functionalized heparin/collagen multilayer with rapid in vivo endothelialization properties10.1021/am401706w ↗
46. Improvements in GORE-TEX vascular graft performance by Carmeda BioActive surface heparin immobilization10.1053/ejvs.2002.1909 ↗
47. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (healthy endothelial accelerated lining inhibits neointimal growth-first in man) registry10.1016/j.jacc.2005.01.048 ↗
48. Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up10.1016/j.ahj.2007.08.031 ↗
49. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients, Catheter10.1002/ccd.21437 ↗
50. CD34 expression on platelets10.1080/0953710031000080577 ↗
51. The innate immune system contributes to tissue-engineered vascular graft performance10.1096/fj.14-268334 ↗
52. Graft vascular disease: immune response meets the vessel wall10.1146/annurev.pathol.3.121806.151449 ↗